CBUS CIBUS INC

Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call

Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call

SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report fourth quarter 2023 financial results on Thursday, March 21, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.

Title: Cibus, Inc. Fourth Quarter 2023 Results Conference Call

Event Date: Thursday, March 21, 2024

Time: 4:30 p.m. ET

Participant Numbers: (U.S.), (International)

Event Link:

For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Thursday, April 4, 2024 and can be accessed by dialing (U.S.), (International) and entering replay passcode: 13743898.

A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.

About Cibus

Cibus is a leader in Gene Edited Productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus’ focus is productivity traits for the major global crops such as canola, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Using its Trait Machine Process, Cibus has developed a pipeline of five productivity traits including important traits for pod shatter reduction, Sclerotinia resistance and weed management. Its initial traits for pod shatter reduction and weed management are developed in collaborations with leading seed companies. Its other pipeline traits including Sclerotinia resistance are in advanced greenhouse and field trial stages.

Cibus Contacts:

Investor Relations

Karen Troeber

858-450-2636

Jeff Sonnek – ICR

Media Relations

Colin Sanford



203-918-4347

 



EN
07/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CIBUS INC

 PRESS RELEASE

Cibus Reports Second Quarter Financial Results and Provides Year-to-Da...

Cibus Reports Second Quarter Financial Results and Provides Year-to-Date Business Update for 2025 Streamlining operational focus on Rice herbicide tolerance traits and partner-funded and/or supported programs, expected to reduce annual cash usage to approximately $30 million by 2026 Commercialization of Rice herbicide tolerance traits HT1 and HT3 on track – targeting an initial commercial launch in Latin America beginning in 2027 and expanding to the U.S. in 2028, with potential annual accessible royalties of over $200 million Signed a collaboration agreement with the Colombia based Rice ...

 PRESS RELEASE

Cibus to Report Second Quarter 2025 Financial Results on August 14, 20...

Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report second quarter 2025 financial results on Thursday, August 14, 2025. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Q...

 PRESS RELEASE

Cibus Announces Steps to Implement More Streamlined Business Focus on ...

Cibus Announces Steps to Implement More Streamlined Business Focus on its Nearest Term Revenue Opportunities Previously Announced Strategy Focus Prioritizes Opportunities in Rice and Biofragrance Products and Sustainable Ingredients with Initiatives Expected to Reduce Annual Net Cash Usage to Approximately $30M by 2026 Cibus Well Situated to Pursue Partner Funding to Support its Advanced Productivity Trait Portfolio SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops plant traits to license to s...

 PRESS RELEASE

The U.S. Food and Drug Administration Completes Review of Cibus’ Alter...

The U.S. Food and Drug Administration Completes Review of Cibus’ Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed Completion of the U.S. Food and Drug Administration’s Plant Biotechnology Consultation Program enables U.S. commercialization of alfalfa with an altered lignin profile offering potential improved digestibility for livestock and greater harvest flexibility for farmers. SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant...

 PRESS RELEASE

Cibus and John Innes Centre Announce Ongoing Collaboration with Potent...

Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming Researchers at the John Innes Centre (JIC) have discovered a genetic mutation with the potential to enhance nutrient uptake and reduce the need for artificial fertilizers Cibus and JIC have agreed on a collaboration with the potential to introduce the trait into several commercial crops Cibus previously announced the successful editing of Canola plants with this mutation and looks forward to further testing and trait validation SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch